{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:31:17Z","timestamp":1783020677579,"version":"3.54.6"},"reference-count":24,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Cytopathology"],"published-print":{"date-parts":[[2026,8]]},"abstract":"ABSTRACT<\/jats:title>\n \n Introduction<\/jats:title>\n Lung adenocarcinoma commonly causes malignant pleural effusion (MPE), a condition with poor prognosis and limited treatment options. Pleural effusion specimens offer a minimally invasive source for diagnosis and molecular testing. This study evaluates cytologic adequacy for molecular analysis, characterizes mutational and PD\u2010L1 profiles, and correlates findings with survival outcomes.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Over 10\u2009years, a review of 2400 MPE identified 94 lung adenocarcinoma cases that underwent next generation sequencing (NGS). Patient demographics, cytological characteristics, molecular features, and survival outcome were integrated for analysis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The mean effusion volume submitted for cytological and molecular testing was 589.8\u2009mL (range 4\u20132790\u2009mL) and mean tumor cellularity was 40% (range 10%\u201390%). NGS identified mutations in 86\/94 cases (91%). TP53 was the most common alteration (42\/94, 44.6%). FDA\u2010approved biomarkers were detected: KRAS (28\/94, 29.7%); EGFR (15\/94, 15.9%); BRAF (8\/94, 8.5%); ALK (3\/94, 4.2%), ROS1 (2\/94, 2.1%), RET fusions (1\/94, 1%); and MET amplification (2\/94, 2.1%). Smoking was associated with bloody effusions (\n p<\/jats:italic>\n \u2009=\u20090.049), frequent TP53 mutations (\n p<\/jats:italic>\n \u2009=\u20090.018), and fewer EGFR mutations (\n p<\/jats:italic>\n \u2009=\u20090.012). Patients with effusions as primary presentation was associated with higher mortality (\n p<\/jats:italic>\n \u2009=\u20090.002), frequent TTF\u20101 positivity (\n p<\/jats:italic>\n \u2009=\u2009<\u20090.001) and frequent BRAF mutations (\n p<\/jats:italic>\n \u2009=\u20090.049). TTF\u20101 positivity was associated with higher PD\u2010L1 scores (\n p<\/jats:italic>\n \u2009=\u20090.035). Survival was shorter in male patients (\n p<\/jats:italic>\n \u2009=\u20090.045), smokers (\n p<\/jats:italic>\n \u2009=\u20090.025), concurrent pericardial effusions (\n p<\/jats:italic>\n \u2009=\u20090.027), and with TP53 mutation (\n p<\/jats:italic>\n \u2009=\u20090.002).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Molecular testing of effusion samples is feasible even at low fluid volumes, provided tumor cellularity is adequate. Prioritizing tumor fraction over volume ensures a higher likelihood of successful molecular analysis. Effusion\u2010based NGS reliably identifies actionable alterations with diagnostic and prognostic relevance. Male patients, smokers, concurrent or primary presentation with MPE, and those with TP53 mutations had poorer outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1002\/dc.70132","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:52:16Z","timestamp":1777265536000},"page":"547-555","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Basics to Benchmarks: Evaluating Sample Adequacy,\n PD<\/scp>\n \u2010\n L1<\/scp>\n Expression, and Molecular Profiling in Effusion Samples of Lung Adenocarcinoma"],"prefix":"10.1002","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-0602","authenticated-orcid":false,"given":"Harpreet","family":"Virk","sequence":"first","affiliation":[{"name":"Department of Pathology University Hospitals Cleveland Medical Center, Case Western Reserve University Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-8644","authenticated-orcid":false,"given":"Claire","family":"Michael","sequence":"additional","affiliation":[{"name":"Department of Pathology University Hospitals Cleveland Medical Center, Case Western Reserve University Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-1667","authenticated-orcid":false,"given":"Keri Ann","family":"Pfeil","sequence":"additional","affiliation":[{"name":"Clinical Research Biostatistician, UH Center for Clinical Research Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5051-717X","authenticated-orcid":false,"given":"Navid","family":"Sadri","sequence":"additional","affiliation":[{"name":"Department of Pathology University Hospitals Cleveland Medical Center, Case Western Reserve University Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-3936","authenticated-orcid":false,"given":"Omid","family":"Savari","sequence":"additional","affiliation":[{"name":"Department of Pathology University Hospitals Cleveland Medical Center, Case Western Reserve University Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-7118","authenticated-orcid":false,"given":"Aparna","family":"Harbhajanka","sequence":"additional","affiliation":[{"name":"Department of Pathology University Hospitals Cleveland Medical Center, Case Western Reserve University Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"1021","article-title":"Pleural Involvement in Lung Cancer","volume":"7","author":"Agalioti T.","year":"2015","journal-title":"Journal of Thoracic Disease"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753466618785098"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12496"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/cyt.12654"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22021"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2024.07.001"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2025.06.002"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.90.6.852"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501824"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.25259\/Cytojournal_18_2021"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep19785"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.70015"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2023.100494"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1957603"},{"issue":"9","key":"e_1_2_8_16_1","first-page":"4650","article-title":"TTF\u20101 and EGFR Expression Are Related to EGFR Mutation in Lung Adenocarcinoma","volume":"11","author":"Chen C.","year":"2018","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.09.013"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0339-0"},{"issue":"3","key":"e_1_2_8_19_1","first-page":"774","article-title":"Distribution of PD\u2010L1 Expression and Its Relationship With Clinicopathological Variables: An Audit From 1071 Cases of Surgically Resected Non\u2010Small Cell Lung Cancer","volume":"12","author":"Chen Q.","year":"2019","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.15146"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-223"},{"key":"e_1_2_8_22_1","article-title":"The Prevalence of Tumour Markers in Malignant Pleural Effusions Associated With Primary Pulmonary Adenocarcinoma: A Retrospective Study","volume":"8","author":"Fjaellegaard K.","year":"2021","journal-title":"European Respiratory Journal"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015450"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.04.125"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02167-9"}],"container-title":["Diagnostic Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dc.70132","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/dc.70132","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dc.70132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:09:24Z","timestamp":1783015764000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dc.70132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1002\/dc.70132"],"URL":"https:\/\/doi.org\/10.1002\/dc.70132","archive":["Portico"],"relation":{},"ISSN":["8755-1039","1097-0339"],"issn-type":[{"value":"8755-1039","type":"print"},{"value":"1097-0339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"2026-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}